COMMUNIQUÉS West-GlobeNewswire

Nasus Pharma to Participate in Upcoming Investor Conferences
01/05/2026
TEL AVIV, Israel, May 01, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, [...]
Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations
01/05/2026
- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive Transformation Plan - [...]
SafeSpace Global Corporation Opens Tennessee AI Center of Excellence, Marking Defining Commercialization Milestone
01/05/2026
Where the Future of American AI-Powered Physical Safety Is Being Built KNOXVILLE, TN., May 01, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation ("SafeSpace" or the "Company") (OTCID: SSGC), a leader in multimodal [...]
WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper
01/05/2026
Hangzhou, China, May 01, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Coloplast Receives Innovative Technology Contract from Vizient for Biatain® Silicone Fit
01/05/2026
The contract is awarded for products that bring improvement to the healthcare industry. Coloplast, a global medical device company and market leader in intimate healthcare, has received an Innovative Technology contract [...]
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
01/05/2026
GERMANTOWN, Md., May 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable [...]
Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026
01/05/2026
Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no [...]
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it [...]
Specialty Nutrition Names Alejandra Gratson Managing Partner, Strengthening Innovation and Commercialization Leadership
01/05/2026
LIGHTHOUSE POINT, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- Specialty Nutrition has named Alejandra Gratson, PhD , managing partner, expanding its leadership in nutrition innovation and commercialization strategy. Gratson [...]
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
01/05/2026
Portage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at Wynn Hotel in Las [...]
Breaking the Silence: Bladder Cancer Awareness Month Begins
01/05/2026
BCAN leads nationwide effort to drive earlier detection and open conversations Bethesda, MD, May 01, 2026 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) today marks the beginning of Bladder Cancer [...]
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
01/05/2026
HEMANGEOL is now available exclusively through Anovo Specialty Pharmacy to streamline access and therapy initiation Eton has integrated full Eton Cares patient support, including $0 co-pay for eligible commercially [...]
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
01/05/2026
-- First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity -- -- European Commission grants authorization in adults and children 4 years of age and above with acquired hypothalamic obesity [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
CLEVELAND, May 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
01/05/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 01, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
InflaRx to Report First Quarter 2026 Results on May 7, 2026
01/05/2026
JENA, Germany, May 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company [...]
Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
01/05/2026
BASEL, Switzerland and BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Noema Pharma AG today announced the presentation of Phase 2a study results evaluating cendifensine in menopausal women experiencing moderate-to-severe [...]
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
01/05/2026
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $22.0 million for the first quarter of 2026, an increase of $2.5 million, or 13%, [...]
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
01/05/2026
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor [...]

Pages